key: cord-0861184-4hfb9p9i
authors: Gadella, Alejandro; Sastre, Miguel Ángel; Maicas, Carolina; Rodríguez-Padial, Luis; Arias, Miguel A.
title: ST-segment elevation myocardial infarction in times of COVID-19: back to the last century? A call for attention
date: 2020-04-24
journal: Rev Esp Cardiol (Engl Ed)
DOI: 10.1016/j.rec.2020.04.009
sha: d120b67fc9c21b9765102bb22233ed5b8613d37b
doc_id: 861184
cord_uid: 4hfb9p9i

nan

Ischemic heart disease is the main cause of death in developed countries. Acute ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of coronary artery disease and is associated with high morbidity and mortality. In the last century, it was well established that early diagnosis and immediate reperfusion by primary percutaneous coronary intervention are the most effective ways to improve overall outcomes by lowering the risk of post-STEMI complications, including mechanical ones. 1 Reperfusion strategies in patients with STEMI are time-dependent and should ideally be implanted within the first 2 hours after the onset of symptoms. 2, 3 The ongoing outbreak of coronavirus disease 2019 (COVID-19) has become a global pandemic.

On 31 January, 2020, Spain confirmed its first COVID-19 case and since then the number of cases has increased exponentially. Early reports noted how the COVID-19 outbreak increased the difficulty of applying the standard of care treatment for STEMI patients. 4 In this disturbing scenario of the COVID-19 pandemic, we report a case of STEMI in a 65-yearold woman with a history of dyslipidemia and chronic hepatitis C virus infection without significant liver disease. The patient, an active smoker, underwent surgery for cervical cancer in 2019. The malignancy was considered inactive and controlled. Due to limitations to freedom of movement in Spain during the COVID-19 lockdown, the patient remained self-isolated at home J o u r n a l P r e -p r o o f for the past 7 days, looking after several grandchildren because school classes were also cancelled.

The patient experienced typical chest pain accompanied by vegetative symptoms but because of her responsibility for looking after her grandchildren, fear of visiting the hospital in the current situation, and awareness of the mandatory need to remain isolated at home, she did not seek medical attention until 24 hours after the onset of symptoms. On arrival at the hospital, the patient reported no longer having chest pain and was hemodynamically stable. She reported a 48-hour history of intermittent low-grade fever and dry cough. The patient was tachypneic and hypoxemic with an oxygen saturation of 88% improving to 98% on 3 liters of oxygen by nasal The present case clearly illustrates how the COVID-19 pandemic can adversely affect STEMI care and its outcomes. Currently, a delay has been observed in all components of STEMI care that may further affect its associated complications and prognosis. 4 On the one hand, people are reluctant to attend hospital despite warning symptoms and, on the other hand, the emergency system is markedly overloaded, leading to a delay in both the diagnosis and treatment of STEMI patients. 4 Despite the lack of solid evidence, various protocols have been published by scientific societies, 5,6 which aim to ensure adequate treatment of the patient with STEMI in this context, with special emphasis also on protection against infection of the health personnel involved.

Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI)

Impact on mortality after implantation of a network for ST-segment elevation myocardial infarction care. The IPHENAMIC study

Spanish Cardiac Catheterization and Coronary Intervention Registry. 28th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology